| Tag | Content |
|---|
EnhancerAtlas ID | HS034-05170 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr11:47939230-47940110 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr11:47939366-47939377 | CATGAGTCACT | - | 6.14 | | MEF2A | MA0052.3 | chr11:47939257-47939269 | TCTATTTTTAGT | - | 6.27 | | MEF2B | MA0660.1 | chr11:47939257-47939269 | TCTATTTTTAGT | - | 6.32 | | MEF2C | MA0497.1 | chr11:47939256-47939271 | TTCTATTTTTAGTAC | - | 7.16 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_34924 | chr11:47933567-47942831 | HeLa | | SE_59342 | chr11:47871465-47957002 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I047912 | chr11 | 47933805 | 47946963 |
|
Enhancer Sequence | GCAGGCCATC ATGGCCAGCT AATTTTTTCT ATTTTTAGTA CAGGTGGAGT TTCACCATGT 60
TGGGACAGGC TGGTCTTGAA CTCCCGGCCT CAAGTGATCC GCTAGCCTTG GCCTCCCAAA 120
GTGCTGGGAT TACAGGCATG AGTCACTGCG CCTGGCTCAG ATTCACATTT TCTTCCTTGT 180
TTATTCACAT TTGTGAACAG CTGGCCAAAA TCAGGCGGTG GCTTGGAGTT GCAGAGGGGG 240
CAGGATTGGA CCCAGGACCT TGTCTGTAAA GCACTTCAGC CAGCCTCCAG TCCTTGAGTG 300
GTGCTTTGCA ATCTTGTGAA GCATTACATG TGAAAAGCCT ATCCAGCCTG CTACCCGCCC 360
CAGACCCTTT ACTGGCCAGA GGAATGTGAT GCTCCGATTG GCCAACCCTG AGTCACATGC 420
CCACTCTTGG AGCGGAAAGT GAAGTGAACT CCAGGAAATG AATTTCTTTG AGGAGCAGAG 480
CCTGAAAAGG GTGTGTAGCT GGTGCCCTGA TAATAAGCCG GGGATGAAGA CACCAGAACG 540
AAGGGTAAAT GGATGCCAGG TGGCAAAACC ACACATGCCC ACCCTTCTGG TTGCTAAGCA 600
ACATTTTGTT TTTCTGCTCT GGTTCCTCTT CTGTTCTGCA AAGCTCGCCT AGCACAAGGG 660
CTGACCATTC TGGAGTTGGA AGAGGGCCAA ACCCAGGGGC CTTGAGTGAA GTGTAAAGAG 720
ATCTGGGCTG GAGATTTGGG TTTTAGTCCT GATATTGCCA CGTACTTTCT TCCCTCCCTG 780
AGTCTCAGTT TTTTCTTCAG CTGTAAGACG AGGAGACTGA ATAGAATCTC TGTGGGGTCC 840
TTGCAATTTA CTAGGCTGGG TTCTGGGCAA TGTCACAGGC 880
|
